Warner Bros. Discovery, Inc.
Biphenyl compound as CCR2/CCR5 receptor antagonist

Last updated:

Abstract:

Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

11 Dec 2017

Issue date:

26 Oct 2021